Proteome Sciences Plc Stock Net Income
| PMSNF Stock | USD 0.04 0.00 0.00% |
As of the 4th of February, Proteome Sciences holds the Coefficient Of Variation of 1073.48, variance of 1440.3, and Risk Adjusted Performance of 0.0782. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Proteome Sciences, as well as the relationship between them. Please check Proteome Sciences plc market risk adjusted performance, variance, as well as the relationship between the Variance and skewness to decide if Proteome Sciences plc is priced some-what accurately, providing market reflects its current price of 0.04 per share. As Proteome Sciences plc appears to be a penny stock we also advise to check out its information ratio numbers.
Proteome Sciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Proteome Sciences' valuation are provided below:Proteome Sciences plc does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Proteome |
Proteome Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Proteome Sciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Proteome Sciences.
| 11/06/2025 |
| 02/04/2026 |
If you would invest 0.00 in Proteome Sciences on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding Proteome Sciences plc or generate 0.0% return on investment in Proteome Sciences over 90 days. Proteome Sciences plc provides contract research services for the identification, validation, and application of protein... More
Proteome Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Proteome Sciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Proteome Sciences plc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0918 | |||
| Maximum Drawdown | 300.0 |
Proteome Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Proteome Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Proteome Sciences' standard deviation. In reality, there are many statistical measures that can use Proteome Sciences historical prices to predict the future Proteome Sciences' volatility.| Risk Adjusted Performance | 0.0782 | |||
| Jensen Alpha | 3.33 | |||
| Total Risk Alpha | 1.3 | |||
| Treynor Ratio | 0.7944 |
Proteome Sciences February 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0782 | |||
| Market Risk Adjusted Performance | 0.8044 | |||
| Mean Deviation | 8.98 | |||
| Coefficient Of Variation | 1073.48 | |||
| Standard Deviation | 37.95 | |||
| Variance | 1440.3 | |||
| Information Ratio | 0.0918 | |||
| Jensen Alpha | 3.33 | |||
| Total Risk Alpha | 1.3 | |||
| Treynor Ratio | 0.7944 | |||
| Maximum Drawdown | 300.0 | |||
| Skewness | 7.46 | |||
| Kurtosis | 59.88 |
Proteome Sciences plc Backtested Returns
Proteome Sciences is out of control given 3 months investment horizon. Proteome Sciences plc maintains Sharpe Ratio (i.e., Efficiency) of 0.0977, which implies the firm had a 0.0977 % return per unit of risk over the last 3 months. We were able to interpolate seventeen different technical indicators, which can help you to evaluate if expected returns of 3.89% are justified by taking the suggested risk. Use Proteome Sciences Risk Adjusted Performance of 0.0782, coefficient of variation of 1073.48, and Variance of 1440.3 to evaluate company specific risk that cannot be diversified away. Proteome Sciences holds a performance score of 7 on a scale of zero to a hundred. The company holds a Beta of 4.44, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Proteome Sciences will likely underperform. Use Proteome Sciences jensen alpha and rate of daily change , to analyze future returns on Proteome Sciences.
Auto-correlation | 0.00 |
No correlation between past and present
Proteome Sciences plc has no correlation between past and present. Overlapping area represents the amount of predictability between Proteome Sciences time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Proteome Sciences plc price movement. The serial correlation of 0.0 indicates that just 0.0% of current Proteome Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Proteome Sciences plc reported net income of 72 K. This is 99.98% lower than that of the Healthcare sector and 99.96% lower than that of the Diagnostics & Research industry. The net income for all United States stocks is 99.99% higher than that of the company.
Proteome Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Proteome Sciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Proteome Sciences could also be used in its relative valuation, which is a method of valuing Proteome Sciences by comparing valuation metrics of similar companies.Proteome Sciences is currently under evaluation in net income category among its peers.
Proteome Fundamentals
| Return On Asset | 0.06 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 25.13 M | |||
| Shares Outstanding | 295.18 M | |||
| Shares Owned By Insiders | 21.49 % | |||
| Shares Owned By Institutions | 22.89 % | |||
| Price To Earning | 50.00 X | |||
| Price To Sales | 2.31 X | |||
| Revenue | 5.13 M | |||
| Gross Profit | 2.96 M | |||
| EBITDA | 625 K | |||
| Net Income | 72 K | |||
| Cash And Equivalents | 3.2 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 11.68 M | |||
| Current Ratio | 0.45 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | 793 K | |||
| Number Of Employees | 27 | |||
| Beta | 0.0015 | |||
| Market Capitalization | 14.76 M | |||
| Total Asset | 10.04 M | |||
| Retained Earnings | (68 M) | |||
| Working Capital | (7 M) | |||
| Current Asset | 2 M | |||
| Current Liabilities | 9 M | |||
| Z Score | -7.8 | |||
| Net Asset | 10.04 M |
About Proteome Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Proteome Sciences plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Proteome Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Proteome Sciences plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Proteome Pink Sheet
Proteome Sciences financial ratios help investors to determine whether Proteome Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Proteome with respect to the benefits of owning Proteome Sciences security.